Cramer’s Mad Cash Recap: Superior Micro Units, Nvidia, Thor

From earnings to developments in China to the latest COVID news, Jim Cramer put his schedule for the next week on during Friday’s Mad Money show.

On Monday, Cramer said he would be checking for the latest updates on China’s Evergrande group, as well as who the next “enemy” of China might be. The country is going through tough times and that makes it difficult for investors and companies.

On Tuesday we receive income from Micron (MU) – Get the report from Micron Technology, Inc. (MU). Let’s see how the company fares, suggested Cramer, while saying he would buy dips from Advanced Micro Devices (AMD) – Get the report from Advanced Micro Devices, Inc. and Nvidia (NVDA) – Get the NVIDIA Corporation report when hit in Micron’s neighborhood. Thor Industries (NS) – Get Thor Industries, Inc. report will also report the receipts.

On Real Money, Jim Cramer writes that if analysts got more real-life experience, they could help people make a lot more money. Instead, they just focus on the wrong things. Read more about what he says about earnings, analysts, and their reactions to Nike, Costco, and Salesforce.

Investors should get a good idea of ​​how small and medium-sized businesses are doing when Cintas (CTAS) – Get the Cintas Corporation report and Herman Miller (MLHR) – Get the Herman Miller, Inc. report announce their quarterly results on Wednesday.

Thursday will be busy with Bed Bath & Beyond (BBBY) – Get the report from Bed Bath & Beyond Inc. Reporting, together with CarMax (KMX) – Get CarMax, Inc. Report. Paychex (PAYX) – Get the Paychex, Inc. report will also report profits and Cramer is happy to buy the dip on that behalf. McCormick (MKC) – Get McCormick & Company, Incorporated (MKC) report will report too, and while it’s a great company, Cramer suggested avoiding that name for now.

On Friday, Cramer would like to take a look at the latest COVID-19 data to see which way the case numbers are headed.

Here’s the bottom line: get ready, said Cramer, because after next week we’ll get the monthly job report and the earnings season will go into effect. Next week is like the “calm before the storm,” he added.

Executive Decision: Good Rx

In the Executive Decision segment of the show, Cramer spoke to Doug Hirsch, Co-Founder and Co-CEO of GoodRx Holdings (GDR) – Get the GoodRx Holdings Inc. report.

In our complicated world of healthcare, GoodRx is just trying to help Americans understand all of the information, Hirsch said.

It takes the average consumer several weeks to get in touch with the doctor, while GoodRx can provide simple answers and videos to help relieve that stress.

The company also works with all of the major US pharmacies as well as retailers like Walmart. together (WMT) – Get the Walmart Inc. Reportto create value for consumers.

The stock has risen since GoodRx was last featured on Monday Money in July (about 14% over the past three months). Cramer said he continues to like it and isn’t worried about potential competition.

Browse Jim Cramer’s “Mad Money” trading recommendations with our exclusive “Mad Money” stock screener.

To sign up for Jim Cramer’s free Booyah! Newsletter with all of his latest articles and videos Please click here.

At the time of publication, Action Alerts PLUS had no position in the stocks mentioned.

FDA must OK rule giving seniors entry to FDA-approved medical gadgets underneath Medicare

Mina De La O | Digital vision | Getty Images

Dr. Anand Shah is an oncologist and former FDA Assistant Commissioner and former Chief Medical Officer of the Center for Medicare & Medicaid Innovation. He is also an advisor to Morgan Stanley.

Navigating public and commercial health insurance to cover innovative medical products can be a never-ending cycle of bureaucracy.

Medical technologies classified as “safe and effective” by the Food and Drug Administration – the global gold standard for regulating drugs and devices – are not always covered by the Centers for Medicare & Medicaid Services, adding the added hurdle for companies Proof of their requirements must be met Product is “reasonable and necessary”.

Unlike medications, which are typically covered by CMS immediately after FDA approval, seniors can only access many FDA cleared or approved medical diagnoses and devices if they can participate in a CMS approved clinical trial. These studies can take years – additional data and a lengthy regulatory process to determine coverage criteria – and in the meantime sustain potentially life-saving medical interventions from Medicare beneficiaries.

A new policy, due to go into effect in mid-March, would have allowed seniors and their doctors to decide whether or not they needed these devices. However, it was postponed along with other pending regulations when the Biden Administration took office. The proposed Medicare Innovative Technologies Coverage Policy, postponed until May 15 for regulatory review, leverages existing FDA legal expertise under the Breakthrough Devices program to identify a limited number of promising medical technologies, and offers these products a short Medicare warranty. granted on the day of FDA approval.

The proposed policy would be a critical step forward for Medicare beneficiaries to make informed decisions about their care.

Currently, the FDA has approved, authorized, or cleared at least 26 breakthrough diagnoses and devices. These medical products include in vitro diagnostic and imaging platforms for implants and wearable devices that cover a range of diseases, including Ebola, traumatic brain injury, severe emphysema, and heart disease.

As an oncologist who helped develop this medical device policy at CMS, I have looked after many patients who have not had access to state-of-the-art tests such as next-generation DNA sequencing as part of a cancer screening because Medicare does not allow them. The same product can often be obtained by the patient through a commercial insurance policy, which many do not get under the Medicare program after aging. As a last resort, the patient has no choice but to pay out of pocket.

Seniors deserve access to FDA-named breakthrough medical devices – narrowly defined by Congress to include the most promising new technologies, such as those that can treat life-threatening or irreversibly debilitating conditions – once the FDA deems them safe and effective.

It is important that the proposed rule maintain the same high standards required by both the FDA and the CMS. In addition, the existing FDA requirements for post-market surveillance will be maintained. This policy bridges the void for patients who would otherwise not have access to the latest FDA authorized technology while waiting for CMS coverage. Still, it encourages researchers to continue collecting real-world evidence of health outcomes that are specific to Medicare beneficiaries.

Patient protection is maintained as MCIT uses existing procedures to restrict access to new technology when safety or efficacy concerns arise.

There is no disadvantage in approving this policy change. Seniors will have more treatment options, and medical technology innovators can work with CMS to carefully examine these patients over a four-year period, generating meaningful real-world evidence to prove that a new device is “sensible and necessary.” “Is Medicare coverage decision and potentially offers more permanent security.

This policy also encourages early investors to support innovation for the most pressing medical conditions as it creates a clear and predictable path – from investing to developing medical products to regulatory review and subsequent patient access.

If the federal government wants to incentivize investment in developing transformative medical innovations and expand choices for our seniors while promoting rigorous evidence generation, MCIT offers a clear way forward. Too many lives depend on it.

Common Electronics Inc. Introduces UEI Digital Agent for Leisure and Sensible Residence Units

SCOTTSDALE, Ariz .– () –Universal Electronics Inc. (UEI) (NASDAQ: UEIC), the world’s leading provider of universal control and sensor technologies for the smart home, is introducing UEI Virtual Agent to provide an AI-powered integrated support framework for entertainment and smart home devices that enables self-help functions.

UEI Virtual Agent is designed to address common onboarding, feature discovery, and troubleshooting challenges for entertainment and smart home devices. UEI Virtual Agent is based on UEI’s white label digital assistant nevo.ai and a comprehensive global device knowledge diagram that covers over a million devices.

In addition to solving user issues related to connected devices, UEI Virtual Agent lowers the cost of managing and supporting an installed base of connected devices for manufacturers and service providers, and integrates easily with the connected device itself, as well as with websites and mobile Apps that offer help when needed.

For connected TV and audio devices, the UEI Virtual Agent can be accessed directly on any screen, including TV, phone, computer and tablet, to guide users through installation and onboarding, setup and troubleshooting. UEI Virtual Agent is also available as a native Android TV application optimized for the TV screen as an additional service with UEI’s industry-leading Android TV voice remote offerings.

For smart home devices, the UEI Virtual Agent is pre-built into QuickSet Widget, a new offering from UEI that OEMs can use to update products to connect to the cloud and be compatible with other devices in the home.

As a stand-alone offering, UEI Virtual Agent can be rapidly deployed on a variety of connected products to enable a full digital transformation of the support experience. In combination with products from UEI QuickSet® 5.0, UEI Virtual Agent provides an enhanced experience of knowing existing home equipment to improve real-time troubleshooting and interoperability.

Launched for UEI-branded devices and support websites in Q3 2020, UEI Virtual Agent will be available to OEMs worldwide for consumer entertainment, air conditioning, and home appliances in Q2 2021. It will initially be available in English. More languages ​​will be available later in 2021.

“UEI Virtual Agent is designed to simplify ongoing on-device and off-device support and enhance the user experience by addressing the toughest aspects of supporting connected devices in an evolving smart home,” said Arsham Hatambeiki, senior vice president for Products and technology at UEI. “Connected products are an ongoing promise brands make to their users, and a framework to support learning is how to ensure that.”

About Universal Electronics Inc.

Universal Electronics Inc. (NASDAQ: UEIC) was founded in 1986 and is the world’s leading provider of universal control and sensor technologies for the smart home. The company designs, develops, manufactures, and ships over 500 innovative products used by the world’s leading brands in the consumer electronics, subscription broadcast, security, home automation, hospitality, and air conditioning markets. For more information, please visit www.uei.com.

QuickSet is a trademark of Universal Electronics Inc.

All other trademarks listed are the property of their respective owners.